Letter to the editor by Casey, Kenneth L.




Ann Arbor, MI, 2 February 1987 
Dear Editor, 
In rejecting unequivocally my major conclusion, Drs. Dubner and Bennett accept 
the position that there are good scientific and clinical reasons for causing an animal 
subject to experience chronic pain as I defined it [l]. I fear that such a position, 
widely held, may lead to the conduct of experiments that invite the imposition of 
severe, even prohibitive, restrictions on animal research in some countries. That is 
why I opened the argument. 
An important justification for many animal models of human disease is that such 
models permit the study of the pathogenesis of a simulated disease by a known or 
suspected agent. Drs. Dubner and Bennett, however, acknowledge that chronic pain 
is not a causal agent, but the object of study. They assert that chronic pain models 
are necessary, even mandatory, to study the therapy and pathophysiology of 
persistent, intractably painful conditions such as those due to primary peripheral or 
central neurologic disease. Unfortunately, my colleagues do not provide evidence to 
support their position. 
Lacking a widely accepted source when I composed my remarks, I defined 
chronic pain as ‘ . . . present during most waking hours for at least 1 week and 
usually much longer’ [l]. The IASP Subcommittee on Taxonomy has subsequently 
published its conclusion that 3 months is the point at which acute pain becomes 
chronic [2]. Is there clinical evidence that the use of any animal model of any 
chronic pain syndrome requires that the subject experience at least a week or more 
of chronic pain - intensity aside? Is there a potentially effective treatment for 
chronic pain that can be tested only under such conditions, or that requires such a 
prolonged observation of chronic pain before effectiveness can be judged? Is there a 
chronic pain syndrome that requires such a prolonged experience of chronic pain 
before the syndrome is established and recognized? In humans, the onset of 
neuropathic or central pain may be delayed or may develop slowly for weeks or 
months after the neurologic damage. But it does not take a week or more of obvious 
pain to establish the condition. And, once established, the syndrome can be 
recognized quickly. If an animal model of neurogenic pain is developed, there is, 
therefore, no reason to withhold treatment of the pain for a week or more after the 
syndrome is recognized. For some studies, euthanasia could be performed as soon as 
the clinical condition has been established. The use of chronic decerebrate prepara- 
tions may be appropriate, as Wall [3] and Woolf [4] suggested. In long-term studies 
of the central nervous system of intact, awake subjects, local or systemic analgesic 
treatment could be periodically withheld for short periods to allow physiological, 
biochemical or pharmacologic observations as necessary. There is no need to restrict 
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scientific investigation to the periphery or to surgically or pharmacologically altered 
central nervous systems, nor was this suggested in my letter. 
The IASP guidelines [5] are not at issue here. Specific issues are most ap- 
propriately handled within the guidelines, which urge peer and lay review and 
indicate generally, but do not specifically define, the boundaries of acceptability 
(e.g., ‘ . . . minimal pain necessary . . . ’ [5]). I support these guidelines and see no 
need to change them to address the details of specific issues. 
No one using animals in pain research wants unnecessarily restrictive limits 
placed on experimentation. I agree fully with Drs. Dubner and Bennett and with 
Dr. Wall [3] that research on pain, especially on chronic intractable pain, must 
proceed apace at peripheral and central levels. It is possible that there are or will be 
sound, ethically acceptable reasons for requiring that, in an animal model, the 
subject experience chronic pain. If so, these reasons must be stated very clearly. 
Meanwhile, we must continue to examine in detail the clinical and scientific reasons 
for the animal models we develop and the limitations that those reasons should 
impose on the conduct of experiments. This will add strength to the case for 
facilitating the continued use of animals in research, especially research relevant to 
the problem of pain. 
Univ. of Michigan Medical Center, 
Chiej Neurology Service, 
Kenneth L. Casey 
Veterans Administration Medical Center, 
Ann Arbor, MI (U.S.A.) 
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